{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:00:54Z","timestamp":1785708054870,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.neurol.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T12:25:47Z","timestamp":1523881547000},"page":"408-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Atypical inflammatory demyelinating lesions and atypical multiple sclerosis"],"prefix":"10.1016","volume":"174","author":[{"given":"X.","family":"Ayrignac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Carra-Dalli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Labauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2018.03.007_bib0385","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1474-4422(16)30043-6","article-title":"Atypical inflammatory demyelinating syndromes of the CNS","volume":"15","author":"Hardy","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0390","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archneurpsyc.1928.02210080044002","volume":"19","author":"Balo","year":"1928","journal-title":"Arch Neurol Psychiatry"},{"key":"10.1016\/j.neurol.2018.03.007_bib0395","first-page":"211","article-title":"Die sogenannte \u201cakute Multiple Sklerose.\u201d","volume":"27","author":"Marburg","year":"1906","journal-title":"J Psychiatr Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02901445","volume":"10","author":"Schilder","year":"1912","journal-title":"Z f d g Neur u Psych"},{"key":"10.1016\/j.neurol.2018.03.007_bib0405","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awh457","article-title":"Tissue preconditioning may explain concentric lesions in Bal\u00f3\u2019s type of multiple sclerosis","volume":"128","author":"Stadelmann","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.03.007_bib0410","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jns.2014.11.024","article-title":"Bal\u00f3\u2019s concentric sclerosis and tumefactive demyelination: a shared immunopathogenesis?","volume":"348","author":"Hardy","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2018.03.007_bib0415","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ncpneuro0519","article-title":"Technology insight: can neuroimaging provide insights into the role of ischemia in Bal\u00f3\u2019s concentric sclerosis?","volume":"3","author":"Mowry","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0420","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/1531-8249(199910)46:4<651::AID-ANA15>3.0.CO;2-Y","article-title":"Serial magnetic resonance imaging in patients with Bal\u00f2\u2019s concentric sclerosis: natural history of lesion development","volume":"46","author":"Chen","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0425","first-page":"1362","article-title":"Bal\u00f3\u2019s concentric sclerosis: clinical and radiologic features of five cases","volume":"22","author":"Karaarslan","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0430","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/1352458507084036","article-title":"Balo's disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese","volume":"14","author":"Wang","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0435","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/00207454.2014.946563","article-title":"Eccentric development of Balo's concentric sclerosis: detected by magnetic resonance diffusion-weighted imaging and magnetic resonance spectroscopy","volume":"125","author":"Chen","year":"2015","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.neurol.2018.03.007_bib0440","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/1352458512445302","article-title":"7Tesla MRI demonstrates vascular pathology in Balo's concentric sclerosis","volume":"19","author":"Berghoff","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0445","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004728-200109000-00008","article-title":"Serial proton magnetic resonance spectroscopy in lesions of Bal\u00f2 concentric sclerosis","volume":"25","author":"Chen","year":"2001","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.neurol.2018.03.007_bib0450","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1552-6569.2012.00760.x","article-title":"Structural and metabolic features of two different variants of multiple sclerosis: a PET\/MRI study","volume":"23","author":"Bolcaen","year":"2013","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.neurol.2018.03.007_bib0455","first-page":"2013","article-title":"Basic and advanced imaging of a case of Bal\u00f2\u2019s concentric sclerosis","author":"Ripellino","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.neurol.2018.03.007_bib0460","first-page":"901","article-title":"Pathology of multiple sclerosis: where do we stand?","volume":"19","author":"Popescu","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.neurol.2018.03.007_bib0465","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1212\/WNL.0000000000003308","article-title":"Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development","volume":"87","author":"Takai","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.03.007_bib0470","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1007\/s00415-013-6918-y","article-title":"Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis","volume":"260","author":"Wallner-Blazek","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0475","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1212\/NXI.0000000000000230","article-title":"Tumefactive brain lesion with rapid cavity formation associated with anti-aquaporin-4 antibody","volume":"3","author":"Uehara","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2018.03.007_bib0480","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jnnp-2012-304498","article-title":"Tumefactive demyelination: an approach to diagnosis and management","volume":"84","author":"Hardy","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2018.03.007_bib0485","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1177\/1352458512438237","article-title":"Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study","volume":"18","author":"Altintas","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0490","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2015.08.034","article-title":"Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations","volume":"358","author":"Jeong","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2018.03.007_bib0495","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00415-015-7758-8","article-title":"Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study","volume":"262","author":"Siri","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0500","doi-asserted-by":"crossref","first-page":"e69919","DOI":"10.1371\/journal.pone.0069919","article-title":"Tumefactive multiple sclerosis in Taiwan","volume":"8","author":"Kuan","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2018.03.007_bib0505","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awn098","article-title":"Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis","volume":"131","author":"Lucchinetti","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.03.007_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-007-0754-x","article-title":"MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: a review of reported findings","volume":"255","author":"Seewann","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0515","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2014.11.027","article-title":"Clinical and radiological characteristics of 17 Chinese patients with pathology confirmed tumefactive demyelinating diseases: follow-up study","volume":"348","author":"Yao","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2018.03.007_bib0520","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3174\/ajnr.A3677","article-title":"Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions","volume":"35","author":"Lu","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0525","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1352458508097922","article-title":"Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy","volume":"15","author":"Malhotra","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0530","first-page":"272","article-title":"Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy","volume":"28","author":"Cianfoni","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0535","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1148\/radiol.2512072071","article-title":"Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging","volume":"251","author":"Kim","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.neurol.2018.03.007_bib0540","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3174\/ajnr.A5089","article-title":"Combining diffusion tensor metrics and DSC perfusion imaging: can it improve the diagnostic accuracy in differentiating tumefactive demyelination from high-grade glioma?","volume":"38","author":"Hiremath","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0545","article-title":"CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma","author":"Ikeguchi","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0550","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-009-0178-z","article-title":"The pathological spectrum of CNS inflammatory demyelinating diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0555","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1600-0404.1992.tb05490.x","article-title":"Acute demyelinating disease. Classification and non-invasive diagnosis","volume":"86","author":"Poser","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2018.03.007_bib0560","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000092785","article-title":"An autopsy case of Schilder's variant of multiple sclerosis (Schilder's disease)","volume":"55","author":"Miyamoto","year":"2006","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0565","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2169\/internalmedicine.52.0425","article-title":"An autopsy case of the Marburg variant of multiple sclerosis (acute multiple sclerosis)","volume":"52","author":"Suzuki","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.neurol.2018.03.007_bib0570","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410400106","article-title":"Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein","volume":"40","author":"Wood","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0575","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.03.007_bib0580","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/1352458511414042","article-title":"A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination","volume":"17","author":"Elenein","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0585","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1474-4422(16)30043-6","article-title":"Atypical inflammatory demyelinating syndromes of the CNS","volume":"15","author":"Hardy","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0590","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1212\/WNL.0000000000002825","article-title":"Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.03.007_bib0595","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00415-015-7694-7","article-title":"Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome","volume":"262","author":"Koelman","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0600","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/1352458513499420","article-title":"Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica","volume":"20","author":"Zhang","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0605","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/archneur.64.10.1426","article-title":"Acute fulminant demyelinating disease: a descriptive study of 60 patients","volume":"64","author":"de Seze","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0610","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/awp321","article-title":"Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis","volume":"133","author":"Young","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.03.007_bib0615","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/WNL.0000000000002723","article-title":"Acute disseminated encephalomyelitis in 228 patients: a retrospective, multicenter US study","volume":"86","author":"Koelman","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.03.007_bib0620","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.56.10.1313","article-title":"Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients","volume":"56","author":"Schwarz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.03.007_bib0625","first-page":"290","article-title":"Hurst acute haemorrhagic leukoencephalitis: MRI findings","volume":"90","author":"Tshibanda","year":"2007","journal-title":"JBR-BTR"},{"key":"10.1016\/j.neurol.2018.03.007_bib0630","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica","volume":"69","author":"Kleiter","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0635","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jns.2014.01.035","article-title":"Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab","volume":"339","author":"Kitley","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2018.03.007_bib0640","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.msard.2016.03.004","article-title":"Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder","volume":"7","author":"Yoshii","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2018.03.007_bib0645","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1177\/1352458517694086","article-title":"Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder","volume":"23","author":"Yamout","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0650","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/archneurol.2008.539","article-title":"Neuromyelitis optica and concentric rings of Bal\u00f3 in the brainstem","volume":"66","author":"Graber","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0655","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-010-0733-7","article-title":"Aquaporin-4 astrocytopathy in Bal\u00f3\u2019s disease","volume":"120","author":"Matsuoka","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0660","article-title":"Central nervous system Aquaporin4 autoimmunity revealed by a single pseudotumoral encephalic lesion","author":"Fargeot","year":"2017","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.neurol.2018.03.007_bib0665","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.03.007_bib0670","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1750-3639.2011.00475.x","article-title":"Reappraisal of aquaporin-4 astrocytopathy in Asian neuromyelitis optica and multiple sclerosis patients","volume":"21","author":"Matsuoka","year":"2011","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0675","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.03.007_bib0680","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0685","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.clineuro.2013.05.006","article-title":"Adult-onset cerebral X-linked adrenoleukodystrophy with major contrast-enhancement mimicking acquired disease","volume":"115","author":"Carra-Dalliere","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neurol.2018.03.007_bib0690","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aww217","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","author":"Stam","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.03.007_bib0695","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1212\/NXI.0000000000000055","article-title":"Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL","volume":"2","author":"Schuh","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2018.03.007_bib0700","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e318247cc8c","article-title":"Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion","volume":"78","author":"Schmalstieg","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.03.007_bib0705","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-017-8595-8","article-title":"Persistence to oral disease-modifying therapies in multiple sclerosis patients","author":"Lattanzi","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0710","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/1352458515570405","article-title":"Solitary sclerosis: experience from three French tertiary care centres","volume":"21","author":"Cohen","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0715","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s13760-016-0711-5","article-title":"Paraplegia related to solitary lesion of the cervicomedullary junction","volume":"117","author":"Taieb","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.neurol.2018.03.007_bib0720","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1212\/WNL.0000000000003235","article-title":"Progressive solitary sclerosis: gradual motor impairment from a single CNS demyelinating lesion","volume":"87","author":"Keegan","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.03.007_bib0725","doi-asserted-by":"crossref","DOI":"10.1007\/s40120-017-0082-8","article-title":"A case report of solitary sclerosis: this is really multiple sclerosis","author":"Lebrun","year":"2017","journal-title":"Neurol Ther"},{"key":"10.1016\/j.neurol.2018.03.007_bib0730","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/brain\/awu397","article-title":"Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis","volume":"138","author":"Weisfeld-Adams","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.03.007_bib0735","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000338476","article-title":"Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesions","volume":"68","author":"Renard","year":"2012","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0740","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/brain\/awp171","article-title":"Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases","volume":"132","author":"Labauge","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.03.007_bib0745","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.neurol.2013.02.010","article-title":"Cavitary lesions in multiple sclerosis: multicenter study on twenty patients","volume":"169","author":"Corlob\u00e9","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2018.03.007_bib0750","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/ene.12931","article-title":"Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease","volume":"23","author":"Ayrignac","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2018.03.007_bib0755","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1177\/1352458513489854","article-title":"A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis","volume":"19","author":"Saitoh","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.03.007_bib0760","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1212\/NXG.0000000000000135","article-title":"Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy","volume":"3","author":"Lakshmanan","year":"2017","journal-title":"Neurol Genet"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378717308512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378717308512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T01:35:43Z","timestamp":1720229743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378717308512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0035378717308512"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2018.03.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical inflammatory demyelinating lesions and atypical multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}